Assessment of corneal epithelial thickness mapping in epithelial basement membrane dystrophy.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 31 01 2020
accepted: 31 08 2020
entrez: 25 11 2020
pubmed: 26 11 2020
medline: 22 12 2020
Statut: epublish

Résumé

To investigate the corneal epithelial thickness topography with optical coherence tomography (OCT) and its relationship with vision quality in epithelial basement membrane dystrophy (EBMD). 45 eyes of EBMD patients, 26 eyes of dry eye (DED) patients and 22 eyes of normal subjects were enrolled. All participants were subjected to 9-mm corneal epithelial mapping with OCT and vision quality was assessed with the optical quality analysis system using the objective scatter index (OSI). Central, superior, inferior, minimum, maximum, and standard deviation of epithelium thickness (Irregularity), were analysed and correlations with the OSI were calculated. The mean (±SD) central, inferior and maximum epithelial thicknesses of the EBMD patients (respectively, 56.4 (±8.1) μm, 58.9 (±6.4) μm, and 67.1 (±8.3) μm) were thicker compared to DED patients (P<0.05) and normal subjects (P<0.05). We found greater irregularity of epithelial thickness in EBMD (5.1±2.5 μm) compared to DED patients (2.6±1.0 μm) (P = 4.4.10-6) and normal subjects (2.1±0.7 μm) (P = 7.6.10-7). The mean OSI was worse in EBMD patients than in DED patients (P = 0.01) and compared to normal subjects (P = 0.02). The OSI correlated with the epithelial thickness irregularity (Spearman coefficient = 0.54; P = 2.65.10-5). The OCT pachymetry map demonstrated that EBMD patients had thicker corneal epithelium in the central and inferior region. These changes were correlated with objective measurements of vision quality. This OCT characterisation of the EMBD provides a better understanding of the epithelial behaviour in this dystrophy and its role in vision quality.

Identifiants

pubmed: 33237913
doi: 10.1371/journal.pone.0239124
pii: PONE-D-20-02872
pmc: PMC7688121
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0239124

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Ophthalmology. 2012 Dec;119(12):2425-33
pubmed: 22917888
J Ophthalmol. 2016;2016:1628469
pubmed: 26925258
Br J Ophthalmol. 1981 Jun;65(6):401-9
pubmed: 7260010
Ocul Surf. 2007 Apr;5(2):75-92
pubmed: 17508116
Ocul Immunol Inflamm. 2018;26(4):632-638
pubmed: 28026971
J Ophthalmol. 2016;2016:2623719
pubmed: 27375899
Trans Am Ophthalmol Soc. 1964;62:213-25
pubmed: 14269893
Jpn J Ophthalmol. 2016 Sep;60(5):357-64
pubmed: 27324656
PLoS One. 2011 Feb 04;6(2):e16823
pubmed: 21326868
Surv Ophthalmol. 2018 May - Jun;63(3):365-380
pubmed: 28801092
Ophthalmology. 2000 Mar;107(3):565-73
pubmed: 10711897
PLoS One. 2015 Feb 03;10(2):e0117587
pubmed: 25646846
Invest Ophthalmol Vis Sci. 2014 Jul 22;55(8):5032-8
pubmed: 25052994
Ophthalmology. 2006 Aug;113(8):1301-8
pubmed: 16877069
Am J Ophthalmol. 2015 Apr;159(4):755-63
pubmed: 25579644
Invest Ophthalmol Vis Sci. 2012 May 04;53(6):2580-5
pubmed: 22427573
Ophthalmology. 1994 Mar;101(3):432-8
pubmed: 8127563
J Fr Ophtalmol. 2015 May;38(5):388-94
pubmed: 25922226
Cornea. 2015 Feb;34(2):117-59
pubmed: 25564336
Br J Ophthalmol. 2016 Mar;100(3):300-6
pubmed: 26781133
Clin Ophthalmol. 2016 Dec 16;11:15-22
pubmed: 28031698
Invest Ophthalmol Vis Sci. 1979 Jan;18(1):93-5
pubmed: 759390
J Refract Surg. 2008 Jun;24(6):571-81
pubmed: 18581782
Transl Vis Sci Technol. 2018 Jul 12;7(4):5
pubmed: 30009091
Am J Ophthalmol. 2014 Jan;157(1):63-68.e2
pubmed: 24200234
Invest Ophthalmol Vis Sci. 2011 Nov 25;52(12):9116-23
pubmed: 22025572
Trans Am Ophthalmol Soc. 1976;74:488-531
pubmed: 301322
Optom Vis Sci. 2010 Sep;87(9):675-81
pubmed: 20581726
J Fr Ophtalmol. 2013 Oct;36(8):e137-40
pubmed: 23731790
Acta Ophthalmol (Copenh). 1988 Jun;66(3):318-26
pubmed: 10994455
Ophthalmology. 2013 Dec;120(12):2403-2412
pubmed: 23932599
Optom Vis Sci. 2014 Dec;91(12):1446-54
pubmed: 25279779
Am J Ophthalmol. 1975 Jun;79(6):925-40
pubmed: 49148
Exp Eye Res. 2009 Aug;89(2):166-71
pubmed: 19298814
Br J Ophthalmol. 1976 Feb;60(2):84-96
pubmed: 1083744
Ophthalmology. 2015 Oct;122(10):2095-102
pubmed: 26189186
Optom Vis Sci. 2006 Jun;83(6):360-5
pubmed: 16772894
Ocul Surf. 2017 Jul;15(3):276-283
pubmed: 28736335
Ann Ophthalmol. 1992 Dec;24(12):471-4
pubmed: 1485744
J Cataract Refract Surg. 2005 Oct;31(10):1932-7
pubmed: 16338563
Cornea. 2019 Jan;38(1):67-73
pubmed: 30379719

Auteurs

Juliette Buffault (J)

Department of Ophthalmology III, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, IHU Foresight, Paris, France.
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC 1423, IHU Foresight, Paris, France.

Pierre Zéboulon (P)

Department of Ophthalmology III, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, IHU Foresight, Paris, France.
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC 1423, IHU Foresight, Paris, France.

Hong Liang (H)

Department of Ophthalmology III, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, IHU Foresight, Paris, France.
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC 1423, IHU Foresight, Paris, France.
Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.

Anthony Chiche (A)

Department of Ophthalmology III, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, IHU Foresight, Paris, France.
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC 1423, IHU Foresight, Paris, France.

Jade Luzu (J)

Department of Ophthalmology III, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, IHU Foresight, Paris, France.
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC 1423, IHU Foresight, Paris, France.

Mathieu Robin (M)

Department of Ophthalmology III, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, IHU Foresight, Paris, France.
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC 1423, IHU Foresight, Paris, France.

Ghislaine Rabut (G)

Department of Ophthalmology III, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, IHU Foresight, Paris, France.
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC 1423, IHU Foresight, Paris, France.

Marc Labetoulle (M)

Department of Ophthalmology, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.

Antoine Labbé (A)

Department of Ophthalmology III, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, IHU Foresight, Paris, France.
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC 1423, IHU Foresight, Paris, France.
Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Department of Ophthalmology, Ambroise Paré Hospital, APHP, Université de Versailles Saint-Quentin en Yvelines, Boulogne-Billancourt, France.

Christophe Baudouin (C)

Department of Ophthalmology III, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, IHU Foresight, Paris, France.
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC 1423, IHU Foresight, Paris, France.
Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Department of Ophthalmology, Ambroise Paré Hospital, APHP, Université de Versailles Saint-Quentin en Yvelines, Boulogne-Billancourt, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH